3-D QSAR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)PROTEASE INHIBITORS

被引：0
|
作者：
WALLER, CL [1 ]
OPREA, TI [1 ]
MARSHALL, GR [1 ]
机构：
[1] WASHINGTON UNIV,SCH MED,CTR MOLEC DESIGN,ST LOUIS,MO 63110
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1993年 / 206卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：87 / MEDI
相关论文
共 50 条
  • [1] GENERATION AND CHARACTERIZATION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) MUTANT RESISTANT TO AN HIV-1 PROTEASE INHIBITOR
    ELFARRASH, MA
    KURODA, MJ
    KITAZAKI, T
    MASUDA, T
    KATO, K
    HATANAKA, M
    HARADA, S
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 233 - 239
  • [2] HIV-1 (HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1) - INFECTION AND DETECTION
    ZEICHHARDT, H
    ZORR, B
    HAMPL, H
    WILLINGMANN, P
    BUCHOW, H
    MAXEINER, HG
    HABERMEHL, KO
    ARZTLICHE LABORATORIUM, 1987, 33 (11): : 253 - 258
  • [3] A ROLE FOR THE ASPARTYL PROTEASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN THE ORCHESTRATION OF VIRUS ASSEMBLY
    NAVIA, MA
    MCKEEVER, BM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 73 - 85
  • [4] MYOPATHY WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - HIV-1 OR ZIDOVUDINE
    TILL, M
    MACDONELL, KB
    ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 492 - 494
  • [5] STUDIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS .3. STRUCTURE-ACTIVITY RELATIONSHIP OF HIV-1 PROTEASE INHIBITORS CONTAINING CYCLOHEXYLALANYLALANINE HYDROXYETHYLENE DIPEPTIDE ISOSTERE
    SAKURAI, M
    HIGASHIDA, S
    SUGANO, M
    HANDA, H
    KOMAI, T
    YAGI, R
    NISHIGAKI, T
    YABE, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (03) : 534 - 540
  • [6] VALIDATION OF A COMFA MODEL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS BASED ON MULTIPLE CONFORMER PREDICTIONS
    OPREA, TI
    WALLER, CL
    MARSHALL, GR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 88 - MEDI
  • [7] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION BY DAPHNODORINS
    YUSA, K
    OHHARA, T
    TSUKAHARA, S
    BABA, K
    TANIGUCHI, M
    KOZAWA, M
    TAKEUCHI, S
    HARA, H
    TSURUO, T
    ANTIVIRAL RESEARCH, 1994, 25 (01) : 57 - 66
  • [8] ANTIRETROVIRAL THERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION
    EMERY, S
    COOPER, DA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (04): : 344 - 349
  • [9] TSAO DERIVATIVES - HIGHLY SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION
    CAMARASA, MJ
    PEREZPEREZ, MJ
    VELAZQUEZ, S
    SANFELIX, A
    ALVAREZ, R
    INGATE, S
    JIMENO, ML
    KARLSSON, A
    DECLERCQ, E
    BALZARINI, J
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5): : 585 - 594
  • [10] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND HUMAN HEMATOPOIETIC PROGENITOR CELLS
    RE, MC
    FURLINI, G
    ZAULI, G
    LAPLACA, M
    ARCHIVES OF VIROLOGY, 1994, 137 (1-2) : 1 - 23
12345